Article · 7 Oct 2025
Research articlePublished 16 Aug 2021
Comparison of Two Muscle Relaxants for Tracheal Intubation in Patients Undergoing Surgery at Goa Medical College and Hospital
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
BACKGROUND Cisatracurium and atracurium are intermediate acting muscle relaxants which do not depend on renal or hepatic metabolism for elimination since they undergo Hofmann elimination. Despite the advantages of cisatracurium such as minimal effects on the cardiovascular system, no accumulative effects, no metabolite toxicity, and metabolic product has no neuromuscular blocking effects, due to slow onset and unsatisfactory intubating conditions, the use of cisatracurium is limited compared with those seen with equipotent doses of other neuromuscular blocking agents. This study was undertaken to find onset time and intubating conditions with 3 × ED95 doses of atracurium versus cisatracurium. METHODS ASA grade 1 or 2 patients, (N = 220) were randomly allocated into 2 groups to receive equipotent doses of either atracurium or cisatracurium. Intubating conditions were assessed using Cooper et al scale and neuromuscular monitoring done using TOF Watch SX. Haemodynamic responses and any adverse effects were noted. RESULTS The onset time was 167.36 ± 75.41 seconds (2.78 ± 1.25 minutes) in atracurium group whereas in cisatracurium group, onset time was 249.26 ± 75.90 seconds (4.15 ± 1.26) and the difference was statistically significant with p value of < 0.001. The difference in intubating conditions between the groups was statistically insignificant. However, atracurium produced a higher incidence of clinically acceptable conditions (excellent in 94.4 %) than cisatracurium (excellent in 87.3 %). The incidence of adverse effects such as erythema, flushing and bronchospasm was greater in Atracurium group though hypotension was observed in both groups. CONCLUSIONS Onset time and intubating conditions are significantly better with equipotent doses of atracurium compared to cisatracurium. But atracurium is associated with higher incidence of adverse effects such as erythema, flushing and bronchospasm, though the potential of cisatracurium to cause anaphylactoid reactions cannot be ignored.
Keywords
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Evidence-Based Medicine and Healthcare.
Article · 28 Jul 2025
Association between Admission Blood Pressure, Stroke Severity and Early Outcome in Thrombolysed Ischemic Stroke Patients: A Single Centre Experience from Northeast India
Article · 28 Mar 2025
Isolated Paralysis of Extensor Indicis and EDC Tendon of Index Finger Following Thompsonandrsquo;s Approach to Proximal Radius-Case Report
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Evidence-Based Medicine and Healthcare
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Anisha Deulker”
- BylineArticles whose byline prints “Rohini Bhat Pai”
- BylineArticles whose byline prints “Shaila Kamat”
- BylineArticles whose byline prints “Eufemia Dias”
- BylineArticles whose byline prints “Rachel Botelho”
- BylineArticles whose byline prints “Gayatri Kamat”
- BylineArticles whose byline prints “Uma Sahakari”
- BylineArticles whose byline prints “Rukmi Pai Raiker”